How can Acousia Therapeutics’ Kv7.4 activators enhance and preserve natural hearing?
Summary
Acousia Therapeutics’ Kv7.4 potassium channel activators enhance the sensitivity, tuning and homeostatic resilience of sensory outer hair cells in the cochlea to treat sensorineural hearing loss by enhancing and preserving natural hearing.
Researcher Profile
